Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month […]
IGM Biosciences (NASDAQ:IGMS) Receives "Sector Perform" Rating from Royal Bank of Canada themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target reduced by HC Wainwright from $22.00 to $17.00 in a research note issued to investors on Monday, MarketBeat reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for IGM Biosciences’ Q3 2023 earnings at ($1.23) EPS, Q4 2023 earnings […]
IGM Biosciences (NASDAQ:IGMS – Get Free Report) had its target price reduced by analysts at Morgan Stanley from $20.00 to $15.00 in a report issued on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective suggests a potential upside of 90.84% from the stock’s previous close. […]
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Recommendation of "Moderate Buy" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.